- Home
- RNAC vs AREN Comparison
RNAC vs AREN Comparison
Compare RNAC & AREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNAC | AREN |
|---|---|---|
| Founded | 2007 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.6M | 208.8M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNAC | AREN |
|---|---|---|
| Price | $8.84 | $4.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $38.40 | $12.00 |
| AVG Volume (30 Days) | ★ 196.3K | 194.3K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.66 |
| Revenue | $1,091,000.00 | ★ $142,815,000.00 |
| Revenue This Year | N/A | $13.89 |
| Revenue Next Year | N/A | $13.81 |
| P/E Ratio | ★ N/A | $1.54 |
| Revenue Growth | N/A | ★ 6.72 |
| 52 Week Low | $5.98 | $1.05 |
| 52 Week High | $23.93 | $10.05 |
Technical Indicators
Market Signals| Indicator | RNAC | AREN |
|---|---|---|
| Relative Strength Index (RSI) | 64.92 | 45.14 |
| Support Level | $6.66 | $3.89 |
| Resistance Level | $8.40 | $4.24 |
| Average True Range (ATR) | 0.54 | 0.26 |
| MACD | 0.26 | 0.04 |
| Stochastic Oscillator | 99.57 | 51.19 |
Price Performance
Historical ComparisonAbout RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About AREN The Arena Group Holdings Inc.
The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.